
A new Northwestern study suggests that interventions for epilepsy can start during pregnancy, as early as 15 weeks gestation, well before symptoms appear, according to a study published in Nature Communications.

Children and adolescents who are reinfected with SARS-CoV-2 face a significantly higher risk of developing long COVID, according to a large, multi-institutional study published in The Lancet Infectious Diseases.

New estimates of rates of sepsis during pediatric hospitalizations have been obtained by a multicenter team of investigators, using clinical data from electronic health records.

Scientists have discovered novel molecular mechanisms that contribute to recovery from diabetic kidney following bariatric surgery in adolescents with type 2 diabetes and obesity, mechanisms that may serve as potential targets for non-surgical treatments for diabetic kidney disease, according to a multi-institutional study published in The Journal of Clinical Investigation.

A first‑ever gene‑regulation therapy tested in early‑phase clinical trials co‑led by Northwestern University Feinberg School of Medicine and Ann & Robert H. Lurie Children’s Hospital of Chicago has proven safe in children with Dravet syndrome who have exhausted conventional treatment options, according to a study published in the New England Journal of Medicine.

An advanced machine learning model predicted spoken language outcomes in children who received cochlear implants more accurately than traditional machine learning approaches, according to a recent Northwestern Medicine-led international multi-center study.

Northwestern University scientists have developed the first device that can continuously track a fetus’s vital signs while still in the uterus — a feat that previously has not been possible.

Early pharmacologic treatment of a common congenital heart defect did not improve survival outcomes compared to expectant management in preterm infants, according to a recent clinical trial published in JAMA.

A new experimental therapy has shown encouraging results in treating a rare and progressive lysosomal storage disorder, according to findings from a multi-year clinical trial published in the New England Journal of Medicine.

A multicenter clinical trial found that intratracheal steroids do not reduce the risk of lung disease or death in extremely preterm infants, according to the study published in JAMA.